Method for increasing the concentration of ascorbic acid in brain tissues of a subject
First Claim
1. A method of treating or preventing a disease or order in a subject which comprises administering to the subject an amount of dehydroascorbic acid or a salt thereof effective to increase the concentration of ascorbic acid in the subject'"'"'s brain tissue, wherein the disease or order is selected from the group consisting of a neurodegenerative disease, a neurovascular disease, a disease which involves the oxidative modification of lowdensity lipoprotein or lipid perioxidation, a behavior disorder, dementia, Huntington'"'"'s Disease and schizophrenia, so as to thereby treat or prevent a disease or order in the subject.
4 Assignments
0 Petitions
Accused Products
Abstract
This invention provides a method for increasing the ascorbic acid concentration in brain tissues of a subject which comprises administering to the subject an amount of dehydroascorbic acid effective to increase the concentration of ascorbic acid in brain tissues. This invention also provides that the dehydroascorbic acid enters the tissues through the facilitative glucose transporter.
64 Citations
9 Claims
- 1. A method of treating or preventing a disease or order in a subject which comprises administering to the subject an amount of dehydroascorbic acid or a salt thereof effective to increase the concentration of ascorbic acid in the subject'"'"'s brain tissue, wherein the disease or order is selected from the group consisting of a neurodegenerative disease, a neurovascular disease, a disease which involves the oxidative modification of lowdensity lipoprotein or lipid perioxidation, a behavior disorder, dementia, Huntington'"'"'s Disease and schizophrenia, so as to thereby treat or prevent a disease or order in the subject.
-
2. A method of treating or preventing a disease or order in a subject which comprises administering to the subject an amount of dehydroascorbic acid or a salt thereof effective to increase antioxidant potential of the subject'"'"'s brain tissue, wherein the disease or order is selected from the group consisting of a neurodegenerative disease, a neurovascular disease, a disease which involves the oxidative modification of lowdensity lipoprotein or lipid perioxidation, a behavior disorder and dementia, Huntington'"'"'s Disease and schizophrenia, so as to thereby treat or prevent a disease or order in the subject.
Specification